Related Experiment Video
Updated: Jul 31, 2026
Live-Cell Imaging Assays to Study Glioblastoma Brain Tumor Stem Cell Migration and Invasion
Published on: August 29, 2018
Current outstanding challenges in germ cell tumors
1Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, Indiana, USA.
Purpose Of Review:
Despite the remarkable advances in the treatment of germ cell tumors (GCT), several challenges remain. This review aims to highlight some of these challenges and provide guidance on how to navigate through them.
Recent Findings:
Patients with International Germ Cell Cancer Collaborative Group poor risk disease have worse prognosis and investigating novel therapeutic interventions are warranted in this population. Patients with brain metastases require a multidisciplinary approach by a group of clinicians experienced in the management of germ cell tumors. Patients with platinum refractory disease have poor prognosis and development of novel treatment options is urgently needed. Conventional tumor markers including alpha fetoprotein and human chorionic gonadotropin remain standard. Development of novel biomarkers to detect minimal residual disease or teratoma is needed.
Summary:
Management of patients with GCT requires a multidisciplinary approach. Patients should preferably be evaluated at tertiary care centers with expertise in the management of this disease.
Insights
Germ cell tumor (GCT) treatment advances continue, but challenges persist, especially for poor-risk patients and those with refractory disease. Multidisciplinary care at specialized centers is crucial for optimal management of these complex GCT cases.
Area of Science:
- Oncology
- Cancer Research
- Genitourinary Cancers
Background:
- Despite significant progress in germ cell tumor (GCT) treatment, critical challenges impede optimal patient outcomes.
- Certain patient subgroups, including those with International Germ Cell Cancer Collaborative Group poor-risk disease or platinum-refractory GCTs, face a poor prognosis.
Approach:
- This review synthesizes current knowledge on persistent challenges in GCT management.
- It emphasizes the need for novel therapeutic strategies and diagnostic biomarkers.
- Highlights the importance of a multidisciplinary approach for complex cases, such as those with brain metastases.
Key Points:
- Investigating novel therapeutic interventions is essential for patients with poor-risk GCT.
- A multidisciplinary approach is vital for managing GCT patients with brain metastases.
- Development of novel biomarkers for minimal residual disease or teratoma detection is needed.
- Conventional tumor markers (AFP, hCG) remain standard, but improved detection methods are required.
Conclusions:
- Effective management of germ cell tumors necessitates a collaborative, multidisciplinary approach.
- Patients with GCT should ideally receive care at tertiary centers with specialized expertise.
- Continued research into novel treatments and biomarkers is critical for improving GCT patient survival and care.
Related Concept Videos
01:24Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
01:20Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...